PRAC recommendations on signals adopted at the 10-13 February 2025 meeting

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 25, Status: Authorised

Template for late submission of ICSRs to EV

PhV non-compliance notification contact points at National Competent Authority (NCA) level

PSUSA/00000406/202408

European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led preparedness reporting for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 10:00 (CET) to 19 February 2025, 12:30 (CET)

Veterinary medicines European public assessment report (EPAR): Prevexxion RN, Marek's disease vaccine (live recombinant), Status: Authorised

Agenda - Management Board meeting: 13 March 2025

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID, Mycoplasma hyopneumoniae and porcine circovirus vaccine (inactivated, recombinant), Status: Authorised

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised